Zuojin Wan Combined with Vonoprazan-Amoxicillin Dual Therapy in H.Pylori Eradication (NCT06901375) | Clinical Trial Compass
Not Yet RecruitingEarly Phase 1
Zuojin Wan Combined with Vonoprazan-Amoxicillin Dual Therapy in H.Pylori Eradication
China136 participantsStarted 2025-05
Plain-language summary
Vonoprazan and high-dose amoxicillin dual therapy was used as a control group to evaluate the clinical efficiency and safety of Zuojin Wan combined with vonoprazan and high-dose amoxicillin dual therapy in the treatment of helicobacter pylori associated chronic gastritis,through a randomized controlled trail.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age 18-65 years old
✓. Patients with H.pylori infection
✓. Diagnosed as functional dyspepsia
✓. Meet the diagnostic criteria of H. pylori liver-atomach stagnation heat syndrome in traditional Chinese medicine.
✓. Patients who have not received H. pylori eradication treatment before, or who have failed eradication in the early stage but have not received eradication treatment within six months.
✓. Volunteer to participate in this experiment and sign the informed consent.
Exclusion criteria
✕. Allergy to research drugs (penicillin allergy, etc.)
✕. Patients with gastric and duodenal ulcer, pyloric obstruction, esophageal and gastric varices, gastrorrhagia, gastrointestinal mucosa with dysplasia, gastric malignant tumor and other gastrointestinal diseases.
✕. Patients with severe heart, brain, liver, kidney, hematopoietic system and connective tissue diseases
✕. Patients who have received H. pylori eradication treatment within six months.
✕. Antibiotics and bismuth were used 4 weeks before the start of study treatment, and histamine H2 receptor antagonist or PPI was used 2 weeks before the start of study treatment.
✕. Use adrenocortical hormone, non-steroidal anti-inflammatory drugs or anticoagulants.
What they're measuring
1
Change from Baseline in functional dyspepsia symptoms at 6 weeks
Timeframe: Baseline and Week 6
2
Change in Traditional Chinese Medicine syndromes from Baseline to 6 weeks
Timeframe: Baseline and Week 6
Trial details
NCT IDNCT06901375
SponsorNanjing First Hospital, Nanjing Medical University